Table 2B. Statistical analyses (ANOVA and nonparametric P-values) of differences in immunohistochemically detected 4E and p4E expressiona.
P-values | 4E cytoplasmic HS | 4E nuclear HS | p4E cytoplasmic HS | p4E nuclear HS |
---|---|---|---|---|
Dermal/compound/junctional nevi | ||||
ANOVA | 0.0324 | 0.9337 | 0.0012 | 0.9907 |
Nonparametric | 0.0775 | 0.7618 | 0.0094 | 0.5241 |
Nevi vs melanomas | ||||
ANOVA | <0.0001 | <0.0001 | <0.0001 | <0.0001 |
Nonparametric | <0.0001 | <0.0001 | <0.0001 | <0.0001 |
Clark level I, II vs ⩾III | ||||
ANOVA | 0.2418 | 0.9298 | 0.2063 | 0.0010 |
Nonparametric | 0.1588 | 0.3503 | 0.1676 | 0.0006 |
Abbreviations: ANOVA=analysis of variance; 4E=cytoplasmic and nuclear eukaryotic translation initiation factor 4E; eIF4E=eukaryotic translation initiation factor 4E; HS=histoscores; p4E=phosphorylated eukaryotic translation initiation factor 4E.
In benign nevi and malignant melanoma histopathologic subtypes and metastatic melanoma expressed as HS=area stained × intensity of stain.